Clinical Trials Directory

Trials / Completed

CompletedNCT02308501

A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
25 (actual)
Sponsor
ORA, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft ® as Measured by In-Vivo Confocal Microscopy

Conditions

Interventions

TypeNameDescription
DRUGLastacaft ®
DRUGTears Naturale ® (Placebo)

Timeline

Start date
2014-12-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2014-12-04
Last updated
2021-03-18
Results posted
2021-03-18

Source: ClinicalTrials.gov record NCT02308501. Inclusion in this directory is not an endorsement.